Mon, May 6, 2024

Nathan Rich Maintained (AMRX) at Strong Buy with Increased Target to $8 on, May 6th, 2024

Nathan Rich of Goldman Sachs, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Strong Buy with Increased Target from $6.25 to $8 on, May 6th, 2024.

Nathan has made no other calls on AMRX in the last 4 months.



There are 2 other peers that have a rating on AMRX. Out of the 2 peers that are also analyzing AMRX, 0 agree with Nathan's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Nathan


  • David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $8 on, Thursday, March 21st, 2024
  • Balaji Prasad of "Barclays" Maintained at Buy with Increased Target to $8 on, Monday, January 29th, 2024